Lung Kee Group Reports Improved Financial Results for 2024

Lung Kee (Bermuda) Holdings Limited ( (HK:0255) ) just unveiled an announcement.

Lung Kee Group Holdings Limited reported its audited consolidated results for the year ending December 31, 2024, showing a revenue increase to HK$1,553,244,000 from HK$1,449,340,000 in 2023. Despite the revenue growth, the company experienced a loss of HK$13,673,000 for the year, an improvement from the previous year’s loss of HK$72,431,000. The total comprehensive expense for the year was HK$62,487,000, compared to HK$118,457,000 in 2023, indicating a reduction in overall expenses. The results reflect challenges in the market, including exchange rate impacts and operational costs, but also highlight the company’s efforts in reducing losses and managing expenses.

More about Lung Kee (Bermuda) Holdings Limited

Lung Kee Group Holdings Limited, formerly known as Lung Kee (Bermuda) Holdings Limited, operates in the manufacturing industry, focusing on the production and distribution of mold bases and related products. The company is listed on the Hong Kong Stock Exchange and serves a diverse market with its industrial offerings.

YTD Price Performance: 12.15%

Average Trading Volume: 132,618

Technical Sentiment Consensus Rating: Buy

Current Market Cap: HK$758M

Find detailed analytics on 0255 stock on TipRanks’ Stock Analysis page.